Marthe Fourcade Bloomberg
- All
- News
-
Intermittent Fasting Linked To Risk Of Death From Heart Disease: Study
The safety of intermittent fasting, a popular strategy to lose weight by limiting food intake to certain times, was called into question by a surprise finding from research presented at a medical meeting.
-
2 New Medicines For Covid Treatment Get WHO Approval
Eli Lilly & Co.'s rheumatoid arthritis drug and GlaxoSmithKline Plc's monoclonal antibody won the backing of World Health Organization experts for treating Covid-19 as new infections surge across the globe.
-
New Variant 'IHU' Hasn't Become Much Of A Threat So Far, Says WHO
The World Health Organization said a coronavirus variant found in France hasn't become much of a threat since it was first identified in November.
-
T-Cells - The Unsung Heroes In The Fight Against Omicron
An unsung arm of the immune system appears to protect against severe disease with the omicron variant even when antibodies wane, helping to explain why a record wave of infections hasn't engulfed hospitals so far.
-
Omicron Not "Same Disease We Were Seeing A Year Ago": Oxford Scientist
The omicron variant that's taking the world by storm is not "the same disease we were seeing a year ago," a University of Oxford immunologist said, reinforcing reports about the strain's milder nature.
-
Masks Cut Covid Risk In Half, New Study Shows
As Covid-19 makes a comeback in Europe, one study offers a reminder that simple measures like mask-wearing and hand-washing help to ward off the disease.
-
Flu's Return Will Shape The Pandemic's Impact In Coming Months
Charting the course of the pandemic during the coming months is likely to involve a more traditional winter nuisance: the flu. As countries lift restrictions and colder temperatures set in, influenza will probably start circulating again.
-
What Happens When You Mix 2 Vaccine Shots? A Study Has Found This
Mixing doses of two leading Covid-19 vaccines increased patients' side effects such as fatigue and headaches in early findings from a study that has yet to show how well such a cocktail defends against the virus.
-
Even A Little Extra Weight Raises Risk Of Severe Covid If Below 40: Study
Carrying even a little extra weight raises the risk of developing a severe form of Covid-19, especially in younger adults, according to a new study.
-
Common Blood Thinning Drugs Reduce Risk Of Covid Hospital Deaths: Study
Blood-thinning drugs reduced the risk of death from Covid-19 in a new study, pointing to one more promising tool as physicians scour their medicine cabinets for treatments to blunt the pandemic.
-
In Coronavirus, Antibodies May Wane, T-Cells Are The New Hero
Antibodies have become a familiar word in the pandemic era, perhaps suggesting they're the best hope for keeping the deadly coronavirus at bay. But when crucial vaccine data was released this week, the spotlight panned to an unsung immune player: T cells.
-
Hospital Staff With Covid-19 Had Antibodies To Prevent Reinfection: Study
Almost all doctors and nurses who got mild forms of Covid-19 produced antibodies that could prevent reinfection, according to a study conducted on hospital staff in northeastern France.
-
Coronavirus Lingers in Air of Crowded Spaces, Unventilated Rooms: Study
The new coronavirus appears to linger in the air in crowded spaces or rooms that lack ventilation, researchers found in a study that buttresses the notion that Covid-19 can spread through tiny airborne particles known as aerosols.
-
Intermittent Fasting Linked To Risk Of Death From Heart Disease: Study
The safety of intermittent fasting, a popular strategy to lose weight by limiting food intake to certain times, was called into question by a surprise finding from research presented at a medical meeting.
-
2 New Medicines For Covid Treatment Get WHO Approval
Eli Lilly & Co.'s rheumatoid arthritis drug and GlaxoSmithKline Plc's monoclonal antibody won the backing of World Health Organization experts for treating Covid-19 as new infections surge across the globe.
-
New Variant 'IHU' Hasn't Become Much Of A Threat So Far, Says WHO
The World Health Organization said a coronavirus variant found in France hasn't become much of a threat since it was first identified in November.
-
T-Cells - The Unsung Heroes In The Fight Against Omicron
An unsung arm of the immune system appears to protect against severe disease with the omicron variant even when antibodies wane, helping to explain why a record wave of infections hasn't engulfed hospitals so far.
-
Omicron Not "Same Disease We Were Seeing A Year Ago": Oxford Scientist
The omicron variant that's taking the world by storm is not "the same disease we were seeing a year ago," a University of Oxford immunologist said, reinforcing reports about the strain's milder nature.
-
Masks Cut Covid Risk In Half, New Study Shows
As Covid-19 makes a comeback in Europe, one study offers a reminder that simple measures like mask-wearing and hand-washing help to ward off the disease.
-
Flu's Return Will Shape The Pandemic's Impact In Coming Months
Charting the course of the pandemic during the coming months is likely to involve a more traditional winter nuisance: the flu. As countries lift restrictions and colder temperatures set in, influenza will probably start circulating again.
-
What Happens When You Mix 2 Vaccine Shots? A Study Has Found This
Mixing doses of two leading Covid-19 vaccines increased patients' side effects such as fatigue and headaches in early findings from a study that has yet to show how well such a cocktail defends against the virus.
-
Even A Little Extra Weight Raises Risk Of Severe Covid If Below 40: Study
Carrying even a little extra weight raises the risk of developing a severe form of Covid-19, especially in younger adults, according to a new study.
-
Common Blood Thinning Drugs Reduce Risk Of Covid Hospital Deaths: Study
Blood-thinning drugs reduced the risk of death from Covid-19 in a new study, pointing to one more promising tool as physicians scour their medicine cabinets for treatments to blunt the pandemic.
-
In Coronavirus, Antibodies May Wane, T-Cells Are The New Hero
Antibodies have become a familiar word in the pandemic era, perhaps suggesting they're the best hope for keeping the deadly coronavirus at bay. But when crucial vaccine data was released this week, the spotlight panned to an unsung immune player: T cells.
-
Hospital Staff With Covid-19 Had Antibodies To Prevent Reinfection: Study
Almost all doctors and nurses who got mild forms of Covid-19 produced antibodies that could prevent reinfection, according to a study conducted on hospital staff in northeastern France.
-
Coronavirus Lingers in Air of Crowded Spaces, Unventilated Rooms: Study
The new coronavirus appears to linger in the air in crowded spaces or rooms that lack ventilation, researchers found in a study that buttresses the notion that Covid-19 can spread through tiny airborne particles known as aerosols.
